Volltext-Downloads (blau) und Frontdoor-Views (grau)

Is Patient centricity the need of the Clinical Trials landscape in India? How can we achieve Patient Centricity in Clinical Trials?

  • Patient engagement is the most important element in the process of research/development of medicinal products and healthcare management in today’s times. In a country like India which has a huge population and limited state of regulatory affairs it becomes important to walk the extra mile to protect the patient lives and truly serve them. Time and again it is seen that there is no or limited focus on patient centric processes and we still tend to focus on sponsors as the key stakeholder. The author in this thesis aims to focus on the clinical trial landscape of India and determine if there is a need to improve the clinical trial processes. If yes, then what type of change is the audience looking for. The author tries to introduce the human element in the process and remind us all that it is the ‘patients’ who are the centre for the drug development process and serving them and alleviating their pain in the true purpose of the process. The author along with the helping us find a definition of patient centricity in India, also proposes a model that can be used by the Indian pharmaceutical companies to focus on patient centricity at different stages of the drug development cycle within their organisations.d
Author:Sarita Thomas
Advisor:Paul Taylor
Document Type:Master's Thesis
Year of Completion:2021
Granting Institution:Hochschule Furtwangen
Date of final exam:2021/02/08
Release Date:2021/04/16
Tag:Clinical trials; Drug development; India; Patient centricity
Page Number:66
Degree Program:MBA - International Business Management
Open-Access-Status: Open Access 
Licence (German):License LogoUrheberrechtlich geschützt